BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33907853)

  • 21. Secreted protein acidic and rich in cysteine expression in human colorectal cancer predicts postoperative prognosis.
    Liu QZ; Gao XH; Chang WJ; Wang HT; Wang H; Cao GW; Fu CG
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1803-11. PubMed ID: 26044224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
    Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
    Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
    Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
    Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.
    Mele V; Muraro MG; Calabrese D; Pfaff D; Amatruda N; Amicarella F; Kvinlaug B; Bocelli-Tyndall C; Martin I; Resink TJ; Heberer M; Oertli D; Terracciano L; Spagnoli GC; Iezzi G
    Int J Cancer; 2014 Jun; 134(11):2583-94. PubMed ID: 24214914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
    Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
    Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy.
    Taghizadeh F; Tang MJ; Tai IT
    Mol Cancer Ther; 2007 Jan; 6(1):309-17. PubMed ID: 17237289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
    J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1-integrin-dependent mechanism.
    Widder M; Lützkendorf J; Caysa H; Unverzagt S; Wickenhauser C; Benndorf RA; Schmoll HJ; Müller-Tidow C; Müller T; Müller LP
    Int J Cancer; 2016 Feb; 138(4):964-75. PubMed ID: 26356035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction with tumor‑associated macrophages promotes PRL‑3‑induced invasion of colorectal cancer cells via MAPK pathway‑induced EMT and NF‑κB signaling‑induced angiogenesis.
    Zhang T; Liu L; Lai W; Zeng Y; Xu H; Lan Q; Su P; Chu Z
    Oncol Rep; 2019 May; 41(5):2790-2802. PubMed ID: 30864736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
    Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.
    Chew A; Salama P; Robbshaw A; Klopcic B; Zeps N; Platell C; Lawrance IC
    PLoS One; 2011; 6(7):e22047. PubMed ID: 21818290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
    Zhang Z; Liu X; Feng B; Liu N; Wu Q; Han Y; Nie Y; Wu K; Shi Y; Fan D
    Oncogene; 2015 Sep; 34(37):4808-20. PubMed ID: 25531324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
    Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
    Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omics Overview of the SPARC Gene in Mesothelioma.
    Wu L; de Perrot M
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.
    Tripodo C; Sangaletti S; Guarnotta C; Piccaluga PP; Cacciatore M; Giuliano M; Franco G; Chiodoni C; Sciandra M; Miotti S; Calvaruso G; Carè A; Florena AM; Scotlandi K; Orazi A; Pileri SA; Colombo MP
    Blood; 2012 Oct; 120(17):3541-54. PubMed ID: 22955913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.